THIRD ROCK VENTURES III, L.P. sold 62.3% of their position (1.90M shares) of JOUNCE THERAPEUTICS, INC. on the open market
Open‑market sale worth $15.92M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/16/2021ACC: 0000899243-21-044916
10% Owner
Since Nov 2021
-1.90M
Net shares
Net seller
$15.92M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.90M disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.90M
Price / share
$8.38
Trade value
$15.92M
% of position
62.3%
11/12/2021
3.05M→1.15M
Total
Net shares
−1.90M
Net value
-$15.92M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/12/2021 | S · Sale | −1.90M | $8.38 | $15.92M | 62.3% | 3.05M | 1.15M |
| Total | −1.90M | -$15.92M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned2.70M
Common Stock
IndirectShares owned283.86K
Common Stock
IndirectShares owned283.85K
Common Stock
IndirectShares owned284.34K
Total
3.55M indirect3.55M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.70M | Indirect |
| Common Stock | 283.86K | Indirect |
| Common Stock | 283.85K | Indirect |
| Common Stock | 284.34K | Indirect |
| Total | 3.55M | 3.55M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported